Giant Biogene Holding Co., Ltd. (HKG: 2367)
Hong Kong
· Delayed Price · Currency is HKD
57.90
+3.50 (6.43%)
Jan 28, 2025, 12:08 PM HKT
Giant Biogene Holding Revenue
Giant Biogene Holding had revenue of 2.54B CNY in the half year ending June 30, 2024, with 157.94% growth. This brings the company's revenue in the last twelve months to 4.46B, up 49.36% year-over-year. In the year 2023, Giant Biogene Holding had annual revenue of 3.52B with 49.05% growth.
Revenue (ttm)
4.46B CNY
Revenue Growth
+49.36%
P/S Ratio
11.76
Revenue / Employee
3.83M CNY
Employees
1,164
Market Cap
58.88B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.52B | 1.16B | 49.05% |
Dec 31, 2022 | 2.36B | 811.96M | 52.30% |
Dec 31, 2021 | 1.55B | 362.01M | 30.41% |
Dec 31, 2020 | 1.19B | 233.78M | 24.44% |
Dec 31, 2019 | 956.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nongfu Spring | 47.68B |
Budweiser Brewing Company APAC | 49.70B |
WH Group | 198.43B |
Tsingtao Brewery Company | 35.35B |
Smoore International Holdings | 12.73B |
China Resources Beer (Holdings) Company | 41.70B |
Tingyi (Cayman Islands) Holding | 86.72B |
New Oriental Education & Technology Group | 37.49B |